Clear Harbor Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History
Clear Harbor Asset Management, LLC
- $1.23 Billion
- Q4 2024
A detailed history of Clear Harbor Asset Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 9,575 shares of BBIO stock, worth $343,168. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,575
Previous 10,800
11.34%
Holding current value
$343,168
Previous $274,000
4.38%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
295Shares Held
170MCall Options Held
10.4MPut Options Held
2.36M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$905 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$900 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$509 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$446 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$217 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.31B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...